U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
1092110921Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate CancerNot yet recruitingNo Results AvailableAdvanced Prostate CancerDrug: Pelvic DCFPyL PET-MRI fusion or PET/MRIhttps://ClinicalTrials.gov/show/NCT02420977
1092210922Effectiveness of Web-based Teaching to Traditional Patient Education in the Use of Injectable Fertility MedicationsCompletedNo Results AvailableInfertilityOther: video instruction|Other: Nurse instructionhttps://ClinicalTrials.gov/show/NCT02420964
1092310923Local Injection of Local Anesthetic 24 Hours After Knee Replacement Surgery May Decrease Pain for Several More HoursNot yet recruitingNo Results AvailableArthroplasty, Knee|PainDrug: Bupivacaine|Other: No Interventionhttps://ClinicalTrials.gov/show/NCT02420951
1092410924Urelumab (CD137 mAb) With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) PatientsRecruitingNo Results AvailableLeukemiaDrug: Rituximab|Drug: Urelumabhttps://ClinicalTrials.gov/show/NCT02420938
1092510925Effect of Celiac Plexus Block on Gastric Emptying and Symptoms Caused by GastroparesisRecruitingNo Results AvailableGastroparesisProcedure: Celiac Plexus Blockhttps://ClinicalTrials.gov/show/NCT02420925
1092610926Nivolumab With Ibrutinib for Relapsed, Refractory or High-Risk Untreated Patients With Chronic Lymphocytic Leukemia (CLL)RecruitingNo Results AvailableLeukemia|Chronic Lymphocytic LeukemiaDrug: Nivolumab|Drug: Ibrutinibhttps://ClinicalTrials.gov/show/NCT02420912
1092710927Different Doses of Rosuvastatin Therapy on Regression of Critical Coronary Atherosclerosis in ACS PatientsRecruitingNo Results AvailableAcute Coronary SyndromeDrug: rosuvastatinhttps://ClinicalTrials.gov/show/NCT02420899
1092810928Adding Cytokine to In Vitro Human Culture Media to Improve Embryogenesis and ImplantationRecruitingNo Results AvailableInfertilityOther: Adding GM-CSF to Lifeglobal human IVF culture mediahttps://ClinicalTrials.gov/show/NCT02420886
1092910929An Open-label Phase II Study of Lorvotuzumab MertansineRecruitingNo Results AvailableLeukemiaDrug: Lorvotuzumab Mertansine (IMGN901)https://ClinicalTrials.gov/show/NCT02420873
1093010930Study of Elotuzumab With Lenalidomide as Maintenance After Autologous Stem Cell Transplant (ASCT)RecruitingNo Results AvailableMyelomaDrug: Elotuzumab|Drug: Dexamethasone acetate|Drug: Diphenhydramine|Drug: Ranitidine|Drug: Lenalidomide|Behavioral: Symptom Questionnairehttps://ClinicalTrials.gov/show/NCT02420860
1093110931A Two-Dimensional Dose-Finding Study of Ixazomib in Combination With Gemcitabine and Doxorubicin, Followed by a Phase II Extension to Assess the Efficacy of This Combination in Metastatic, Surgically Unresectable Urothelial CancerRecruitingNo Results AvailableBladder CancerDrug: Ixazomib|Drug: Gemcitabine|Drug: Doxorubicinhttps://ClinicalTrials.gov/show/NCT02420847
1093210932Dry Eye Treatment With Artificial TearsRecruitingNo Results AvailableDry EyeOther: Hypromellose 0.15%|Other: Hypromellose 0.4%|Other: Carboxymethylcellulose|Other: Liposomal Sprayhttps://ClinicalTrials.gov/show/NCT02420834
1093310933A Phase III, Open-Label, Randomized Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Patients With Untreated Advance Renal Cell Carcinoma [IMmotion151]RecruitingNo Results AvailableRenal Cell CarcinomaDrug: Atezolizumab|Drug: Bevacizumab|Drug: Sunitinibhttps://ClinicalTrials.gov/show/NCT02420821
1093410934An Epidemiological Cohort Study of Acute Coronary Syndromes in The Greek Population. The PHAETHON StudyCompletedNo Results AvailableCoronary Artery Diseasehttps://ClinicalTrials.gov/show/NCT02420808
1093510935Study of Oral ONC201 in Patients With Relapsed/Refractory Non-Hodgkin's LymphomaNot yet recruitingNo Results AvailableLymphomaDrug: ONC201|Behavioral: Phone Callhttps://ClinicalTrials.gov/show/NCT02420795
1093610936First-in-human: Single Ascending Dose, Food Effect, Drug-drug Interaction, Multiple Ascending Dose, Proof of PharmacologySuspendedNo Results AvailableHealthy VolunteersDrug: ASP6282|Drug: Itraconazole|Drug: Pilocarpine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02420782
1093710937Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened AbortionRecruitingNo Results AvailableThreatened Abortionhttps://ClinicalTrials.gov/show/NCT02420769
1093810938Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) StudyNot yet recruitingNo Results AvailableAlzheimer's Disease|Dementia|Mild Cognitive ImpairmentDevice: PET Scanhttps://ClinicalTrials.gov/show/NCT02420756
1093910939Serum Ferritin Concentration and Fetal MCA Doppler as Predictors for Preterm DeliveryRecruitingNo Results AvailablePreterm DeliveryProcedure: serum ferritin|Procedure: MCA Dopplerhttps://ClinicalTrials.gov/show/NCT02420743
1094010940Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry EyeRecruitingNo Results AvailableHealthy Volunteers|Dry Eye SyndromesDrug: AGN-232411|Drug: AGN-232411 Vehiclehttps://ClinicalTrials.gov/show/NCT02420730
1094110941Ruxolitinib or Dasatinib With Chemotherapy in Patients With Philadelphia Chromosome (Ph)-Like Acute Lymphoblastic Leukemia (ALL)RecruitingNo Results AvailableLeukemiaDrug: Ruxolitinib|Drug: Dasatinib|Drug: Rituximab|Drug: G-CSF|Drug: Pegfilgrastim|Drug: Methotrexate|Drug: Cytarabine|Drug: Cyclophosphamide|Drug: Mesna|Drug: Doxorubicin|Drug: Vincristine|Drug: Dexamethasone|Drug: Solumedrol|Drug: 6-mercaptopurine|Drug: Prednisone|Drug: Leucovorinhttps://ClinicalTrials.gov/show/NCT02420717
1094210942Effect of Endometrial Thickness on IVF OutcomeRecruitingNo Results AvailableInfertilityProcedure: Embryo transferhttps://ClinicalTrials.gov/show/NCT02420704
1094310943LEE011 in Neuroendocrine Tumors of Foregut OriginRecruitingNo Results AvailableGastrointestinal CancerDrug: LEE011https://ClinicalTrials.gov/show/NCT02420691
1094410944Quality of Life in Patients With Hepatocellular CarcinomaRecruitingNo Results AvailableHepatocellular Carcinomahttps://ClinicalTrials.gov/show/NCT02420678
1094510945Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical DysplasiaRecruitingNo Results AvailableCervical CancerDrug: Proflavine|Device: HRME Imaging|Behavioral: Phone Call|Procedure: Colposcopy|Drug: Acetic Acidhttps://ClinicalTrials.gov/show/NCT02420665
1094610946Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation TherapyNot yet recruitingNo Results AvailableRecurrent Prostate Carcinoma|Stage I Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer|Stage III Prostate CancerDrug: Aspirin|Other: Laboratory Biomarker Analysis|Drug: Metformin Hydrochloride|Other: Placebo|Other: Placebohttps://ClinicalTrials.gov/show/NCT02420652
1094710947Prospective, Interventional Study Evaluating the Feasibility and Safety of the Esophageal Cooling DeviceRecruitingNo Results AvailableTraumatic Brain InjuryDevice: Esophageal Cooling Device (ECD), manufactured by Advanced Cooling Therapy, Inc.https://ClinicalTrials.gov/show/NCT02420639
1094810948Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter SystemNot yet recruitingNo Results AvailablePulmonary Embolism|Venous Thromboembolism|Deep Vein Thrombosishttps://ClinicalTrials.gov/show/NCT02420626
1094910949Study of Suberoylanilide Hydroxamic Acid (SAHA) With Temsirolimus in Children With Diffuse Intrinsic Pontine Glioma (DIPG)Not yet recruitingNo Results AvailableDiffuse Intrinsic Pontine GliomaDrug: Vorinostat|Radiation: Radiation Therapy|Drug: Temsirolimushttps://ClinicalTrials.gov/show/NCT02420613
1095010950The Clinical Relevance of Immune Cells and CTC in HNSCC PatientsRecruitingNo Results AvailableRecurrence|Metastasis|Deathhttps://ClinicalTrials.gov/show/NCT02420600

* Görseller ve İçerik tekif hakkına sahip olabilir